(lp0
S'Paratek Pharmaceuticals, Inc. to Present at LEERINK Partners 6th Annual Global ... GlobeNewswire  - Feb 8, 2017 BOSTON, Feb. 08, 2017  -- Paratek Pharmaceuticals, Inc.  today announced that its President and Chief Operating Officer, Evan Loh, MD, will participate in the LEERINK Partners 6th Annual Global Healthcare Conference&nbsp;...Paratek: CABP Read-Out Likely Positive - Seeking Alpha'
p1
aS'Dissecting And Analyzing The Special Situation In Paratek Pharmaceuticals, Inc. Seeking Alpha - Jan 17, 2017 We then briefly introduced the Reader to Paratek Pharmaceuticals for consideration of a special situation investment, and we ran some probability-weighted, risk-adjusted calculations to arrive at expected annualized returns on investment in order to&nbsp;...Paratek Announces Completion of Enrollment in Omadacycline Phase 3 Community ... - GlobeNewswire '
p2
aS'Paratek Pharmaceuticals Inc. PRTK  Wall Street Journal - Oct 31, 2014 News Paratek Pharmaceuticals Inc.PRTK. Significant News Only. 03/02/17; Press Release. Paratek Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter 2016 Financial Results and Provides Clinical Update. Press Release. 02/22/17; Press Release.'
p3
aS'Cempra Longs Can Make Their Money Back With Paratek Seeking Alpha - Nov 3, 2016 Cempra Longs Can Make Their Money Back With Paratek. Nov. 3.16 | About: Paratek Pharmaceuticals, . This article is now exclusive for PRO subscribers.'
p4
aS'Omadacycline is shown to be non-inferior to linezolid. Seeking Alpha - Mar 13, 2017 Paratek Pharmaceuticals  has a lot going for it - it has an NDA upcoming in 2018 based on successful acute bacterial skin and skin structure infections  trial  of its drug candidate omadacycline.'
p5
aS'Paratek Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 15 Equities.com - Mar 15, 2017 Paratek Pharmaceuticals Inc.  traded on unusually high volume on Mar. 15, as the stock gained 1.5% to close at $16.90.The Paratek Pharmaceuticals Inc  Receives Average Rating of Buy from ... - Petro Global News 24Review of Price Trends: Paratek Pharmaceuticals, Inc.  - Is stories'
p6
aS'Paratek Pharmaceuticals Completes Merger With Transcept Pharmaceuticals GlobeNewswire  - Oct 30, 2014 BOSTON, Oct. 30, 2014  -- Paratek Pharmaceuticals, Inc.  and Transcept Pharmaceuticals, Inc.   today announced the two companies have completed their merger effective as of&nbsp;...'
p7
aS'Paratek Pharmaceuticals Is A Buy For Its Broad-Spectrum Tetracycline Antibiotic Seeking Alpha - May 27, 2016 Paratek Pharmaceuticals is a Boston, Massachusetts based pharmaceuticals company, whose key product in the development is omadacycline, a broad spectrum aminomethylcycline  class of antibiotic.'
p8
aS'Paratek Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 09 Equities.com - Mar 9, 2017 Paratek Pharmaceuticals Inc.  traded on unusually high volume on Mar. 09, as the stock lost 3.82% to close at $16.35.The Paratek Pharmaceuticals Inc  Upgraded to Hold by Zacks Investment ... - DailyQuint'
p9
aS"Paratek Pharmaceuticals Strengthens Senior Leadership Team GlobeNewswire  - Jun 3, 2015 BOSTON, June 3, 2015  -- Paratek Pharmaceuticals, Inc.  today announced the addition of two experienced pharmaceutical executives to the company's senior leadership team to meet the company's growing needs as it&nbsp;..."
p10
a.